BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oak S, Gilliam LK, Landin-Olsson M, Törn C, Kockum I, Pennington CR, Rowley MJ, Christie MR, Banga JP, Hampe CS. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci USA. 2008;105:5471-5476. [PMID: 18367670 DOI: 10.1073/pnas.0800578105] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Eisenbarth GS. Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes. Diabetes 2010;59:759-74. [PMID: 20350969 DOI: 10.2337/db09-1855] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
2 Pipi E, Marketou M, Tsirogianni A. Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus. World J Diabetes 2014; 5(4): 505-510 [PMID: 25126396 DOI: 10.4239/wjd.v5.i4.505] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
3 Stenberg P, Roth B, Wollheim FA. Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease. Eur J Intern Med 2009;20:749-55. [PMID: 19892302 DOI: 10.1016/j.ejim.2009.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
4 Blachère NE, Orange DE, Gantman EC, Santomasso BD, Couture GC, Ramirez-Montagut T, Fak J, O'Donovan KJ, Ru Z, Parveen S, Frank MO, Moore MJ, Darnell RB. T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy. JCI Insight 2017;2:96173. [PMID: 29093272 DOI: 10.1172/jci.insight.96173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Wenzlau JM, Walter M, Gardner TJ, Frisch LM, Yu L, Eisenbarth GS, Ziegler AG, Davidson HW, Hutton JC. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab 2010;95:4712-9. [PMID: 20610599 DOI: 10.1210/jc.2010-0169] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
6 Oak S, Gaur LK, Radtke J, Patel R, Iyer D, Ram N, Gaba R, Balasubramanyam A, Hampe CS. Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes. J Clin Endocrinol Metab 2014;99:E1040-4. [PMID: 24601691 DOI: 10.1210/jc.2013-4189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 Sabek OM, Redondo MJ, Nguyen DT, Beamish CA, Fraga DW, Hampe CS, Mulukutla SN, Graviss EA, Gaber AO. Serum C-peptide and osteocalcin levels in children with recently diagnosed diabetes. Endocrinol Diabetes Metab 2020;3:e00104. [PMID: 31922031 DOI: 10.1002/edm2.104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Review of Clinical Immunology 2014;9:1043-53. [DOI: 10.1586/1744666x.2013.845527] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
9 Piccolo G, Tavazzi E, Cavallaro T, Romani A, Scelsi R, Martino G. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies. Journal of the Neurological Sciences 2010;290:148-9. [DOI: 10.1016/j.jns.2009.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hampe CS. Protective role of anti-idiotypic antibodies in autoimmunity – Lessons for type 1 diabetes. Autoimmunity 2012;45:320-31. [DOI: 10.3109/08916934.2012.659299] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
11 La Torre D. Immunobiology of beta-cell destruction. Adv Exp Med Biol 2012;771:194-218. [PMID: 23393680 DOI: 10.1007/978-1-4614-5441-0_16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
12 Holmøy T, Geis C. The immunological basis for treatment of stiff person syndrome. Journal of Neuroimmunology 2011;231:55-60. [DOI: 10.1016/j.jneuroim.2010.09.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
13 Redondo MJ, Muniz J, Rodriguez LM, Iyer D, Vaziri-Sani F, Haymond MW, Hampe CS, Metzker ML, Grant SF, Balasubramanyam A. Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes. BMJ Open Diabetes Res Care 2014;2:e000008. [PMID: 25452857 DOI: 10.1136/bmjdrc-2013-000008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
14 Cui Z, Zhao MH, Segelmark M, Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 2010;78:590-7. [PMID: 20592714 DOI: 10.1038/ki.2010.198] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 7.0] [Reference Citation Analysis]
15 Routsias JG, Tzioufas AG. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: Tools to study the regulation of the autoimmune response. Journal of Autoimmunity 2010;35:256-64. [DOI: 10.1016/j.jaut.2010.06.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
16 Odales J, Guzman Valle J, Martínez-Cortés F, Manoutcharian K. Immunogenic properties of immunoglobulin superfamily members within complex biological networks. Cell Immunol 2020;358:104235. [PMID: 33137645 DOI: 10.1016/j.cellimm.2020.104235] [Reference Citation Analysis]
17 Tzioufas AG, Tatouli IP, Moutsopoulos HM. Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms. Presse Med 2012;41:e451-60. [PMID: 22840991 DOI: 10.1016/j.lpm.2012.05.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bansal N, Hampe CS, Rodriguez L, O'Brian Smith E, Kushner J, Balasubramanyam A, Redondo MJ. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes. Diabet Med 2017;34:641-6. [PMID: 26802570 DOI: 10.1111/dme.13077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Selleng K, Warkentin TE, Sheppard JI, Greinacher A. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies: IDIOTYPE/ANTI-IDIOTYPE NETWORK IN HIT. Transfusion 2009;49:1812-8. [DOI: 10.1111/j.1537-2995.2009.02205.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 Jiang W, Macmillan H, Madec AM, Mellins ED. Optimized purification strategies for the elimination of non-specific products in the isolation of GAD65-specific monoclonal autoantibodies. F1000Res 2015;4:135. [PMID: 29167731 DOI: 10.12688/f1000research.6467.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
21 Martínez D, Pupo A, Cabrera L, Raymond J, Holodick NE, Hernández AM. B-CD8+ T Cell Interactions in the Anti-Idiotypic Response against a Self-Antibody. J Immunol Res 2017;2017:2860867. [PMID: 28491873 DOI: 10.1155/2017/2860867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Berger M, McCallus DE, Lin CS. Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies. J Peripher Nerv Syst 2013;18:275-96. [PMID: 24200120 DOI: 10.1111/jns5.12048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
23 Moscavitch SD, Szyper-Kravitz M, Shoenfeld Y. Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: the olfactory and immune system interrelationship. Clin Immunol. 2009;130:235-243. [PMID: 19097945 DOI: 10.1016/j.clim.2008.10.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
24 Vaziri-Sani F, Oak S, Radtke J, Lernmark K, Lynch K, Agardh CD, Cilio CM, Lethagen AL, Ortqvist E, Landin-Olsson M. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity. 2010;43:598-606. [PMID: 20298127 DOI: 10.3109/08916930903555927] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
25 Jacobsen JT, Lunde E, Sundvold-Gjerstad V, Munthe LA, Bogen B. The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation. Immunol Cell Biol 2010;88:515-22. [PMID: 20066000 DOI: 10.1038/icb.2009.118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
26 Routsias JG, Kyriakidis NC, Friedman DM, Llanos C, Clancy R, Moutsopoulos HM, Buyon J, Tzioufas AG. Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. Arthritis Rheum 2011;63:2783-9. [PMID: 21618202 DOI: 10.1002/art.30464] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
27 Uibo R, Lernmark Å. Chapter 3 GAD65 Autoimmunity—Clinical Studies. Immunopathogenesis of Type 1 Diabetes Mellitus. Elsevier; 2008. pp. 39-78. [DOI: 10.1016/s0065-2776(08)00803-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
28 Quaglia S, Ferrara F, De Leo L, Ziberna F, Vatta S, Marchiò S, Sblattero D, Ventura A, Not T. A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies. J Immunol 2019;202:1079-87. [PMID: 30635394 DOI: 10.4049/jimmunol.1800819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Rubí B. Pyridoxal 5'-phosphate (PLP) deficiency might contribute to the onset of type I diabetes. Med Hypotheses 2012;78:179-82. [PMID: 22088923 DOI: 10.1016/j.mehy.2011.10.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
30 Aas-Hanssen K, Funderud A, Thompson KM, Bogen B, Munthe LA. Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus. J Immunol 2014;193:2691-8. [PMID: 25127856 DOI: 10.4049/jimmunol.1400640] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
31 Tsirogianni A, Pipi E, Soufleros K. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. Autoimmun Rev. 2009;8:687-691. [PMID: 19217947 DOI: 10.1016/j.autrev.2009.02.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
32 La Torre D, Lernmark A. Immunology of beta-cell destruction. Adv Exp Med Biol 2010;654:537-83. [PMID: 20217514 DOI: 10.1007/978-90-481-3271-3_24] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
33 Larsson HE, Lernmark Å. Vaccination against type 1 diabetes. J Intern Med 2011;269:626-35. [PMID: 21481019 DOI: 10.1111/j.1365-2796.2011.02386.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
34 Sullivan MA, Wentworth T, Kobie JJ, Sanz I. Anti-idiotypic monobodies for immune response profiling. Methods 2012;58:62-8. [PMID: 22819856 DOI: 10.1016/j.ymeth.2012.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
35 Larsson HE, Jönsson I, Lernmark A, Ivarsson S, Radtke JR, Hampe CS; Diabetes Prediction in Skåne (DiPiS)., Type 1 Diabetes Trial Network. Decline in titers of anti-idiotypic antibodies specific to autoantibodies to GAD65 (GAD65Ab) precedes development of GAD65Ab and type 1 diabetes. PLoS One 2013;8:e65173. [PMID: 23785410 DOI: 10.1371/journal.pone.0065173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
36 Richardson CC, McLaughlin KA, Brown TJ, Morgan D, Feltbower R, Powell M, Furmaniak J, Rees Smith B, Christie MR. Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes. Autoimmunity 2013;46:375-81. [PMID: 24001205 DOI: 10.3109/08916934.2013.773978] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Wang X, Zhang A, Liu Y, Chen S, Feng Z, Shang W, Maziarz M, Radtke J, Hampe CS. Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse. PLoS One 2012;7:e32515. [PMID: 22384267 DOI: 10.1371/journal.pone.0032515] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
38 Ortqvist E, Brooks-Worrell B, Lynch K, Radtke J, Bekris LM, Kockum I, Agardh CD, Cilio CM, Lethagen AL, Persson B, Lernmark A, Reichow J, Oak S, Palmer JP, Hampe CS. Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity. J Clin Endocrinol Metab 2010;95:E310-8. [PMID: 20685858 DOI: 10.1210/jc.2010-0785] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
39 Lemke H. Immune Response Regulation by Antigen Receptors' Clone-Specific Nonself Parts. Front Immunol 2018;9:1471. [PMID: 30034389 DOI: 10.3389/fimmu.2018.01471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
40 Harding FA, Stickler MM, Razo J, DuBridge RB. The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. MAbs. 2010;2:256-265. [PMID: 20400861 DOI: 10.4161/mabs.2.3.11641] [Cited by in Crossref: 371] [Cited by in F6Publishing: 348] [Article Influence: 30.9] [Reference Citation Analysis]
41 Jacobsen J, Haabeth OA, Tveita AA, Schjetne KW, Munthe LA, Bogen B. Naive idiotope-specific B and T cells collaborate efficiently in the absence of dendritic cells. J Immunol 2014;192:4174-83. [PMID: 24706724 DOI: 10.4049/jimmunol.1302359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
42 Oak S, Radtke J, Landin-Olsson M, Törn C, Lernmark A, Hampe CS. Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies. J Immunol Methods 2009;351:55-61. [PMID: 19781546 DOI: 10.1016/j.jim.2009.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
43 Bloem SJ, Roep BO. The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes. Diabetologia 2017;60:1185-9. [PMID: 28439640 DOI: 10.1007/s00125-017-4284-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
44 Sørensen JØ, Buschard K, Brogren CH. The preventive role of type 2 NKT cells in the development of type 1 diabetes. APMIS 2014;122:167-82. [PMID: 23992281 DOI: 10.1111/apm.12140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
45 Oak S, Radtke J, Törn C, Landin-Olsson M, Hampe CS. Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals. Scand J Immunol 2011;74:363-7. [PMID: 21517929 DOI: 10.1111/j.1365-3083.2011.02565.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
46 Tzioufas AG, Routsias JG. Idiotype, anti-idiotype network of autoantibodies: pathogenetic considerations and clinical application. Autoimmun Rev. 2010;9:631-633. [PMID: 20478412 DOI: 10.1016/j.autrev.2010.05.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
47 Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B. The idiotype connection: linking infection and multiple sclerosis. Trends Immunol 2010;31:56-62. [PMID: 19962346 DOI: 10.1016/j.it.2009.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
48 Fredriksen AB, Sandlie I, Bogen B. Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells. Front Oncol 2012;2:154. [PMID: 23115759 DOI: 10.3389/fonc.2012.00154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
49 Redondo MJ, Rodriguez LM, Haymond MW, Hampe CS, Smith EO, Balasubramanyam A, Devaraj S. Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2014;15:543-549. [PMID: 24978596 DOI: 10.1111/pedi.12159] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
50 Redondo MJ, Shirkey BA, Fraga DW, Gaber AO, Sabek OM. Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes. Pediatr Diabetes 2017;18:869-73. [PMID: 28093839 DOI: 10.1111/pedi.12501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
51 Parsons MS, Muller S, Kohler H, Grant MD, Bernard NF. On the benefits of sin: Can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development? Human Vaccines & Immunotherapeutics 2013;9:1532-8. [DOI: 10.4161/hv.24460] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
52 Pan SY, Chia YC, Yee HR, Fang Cheng AY, Anjum CE, Kenisi Y, Chan MK, Wong MB. Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases. Future Sci OA 2020;7:FSO648. [PMID: 33437514 DOI: 10.2144/fsoa-2020-0142] [Reference Citation Analysis]
53 Delli AJ, Lernmark Å. Type 1 (Insulin-Dependent) Diabetes Mellitus. Endocrinology: Adult and Pediatric. Elsevier; 2016. pp. 672-690.e5. [DOI: 10.1016/b978-0-323-18907-1.00039-1] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
54 Jiang W, Macmillan H, Madec A, Mellins ED. Purification and characterization of GAD65-specific monoclonal autoantibodies. F1000Res 2015;4:135. [DOI: 10.12688/f1000research.6467.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Stanova AK, Ryabkova VA, Utekhin SV, Shoenfeld VJ, Churilov LP, Shoenfeld Y. Anti-Idiotypic Agonistic Antibodies: Candidates for the Role of Universal Remedy. Antibodies (Basel) 2020;9:E19. [PMID: 32481667 DOI: 10.3390/antib9020019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Palmer MT, Weaver CT. Autoimmunity: increasing suspects in the CD4+ T cell lineup. Nat Immunol 2010;11:36-40. [PMID: 20016508 DOI: 10.1038/ni.1802] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]